Stock ATT ATTENDO AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Attendo AB

Equities

ATT

SE0007666110

Healthcare Facilities & Services

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:47 2024-04-26 am EDT 		5-day change 1st Jan Change
42.3 SEK +1.93% Intraday chart for Attendo AB -11.23% +17.17%
Apr. 24 Attendo AB Approves Dividend, Payable on 2 May, 2024 CI
Apr. 24 Attendo AB Approves Election of Nomination Committee Members CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 8,679 7,141 6,195 3,898 5,810 6,728 -
Enterprise Value (EV) 1 20,510 19,401 19,559 18,196 19,636 22,392 22,491
P/E ratio 106 x -7.88 x 110 x -86.5 x 15.5 x 14.4 x 11.4 x
Yield - - - - 2.77% 2.93% 3.38%
Capitalization / Revenue 0.73 x 0.58 x 0.48 x 0.27 x 0.34 x 0.35 x 0.35 x
EV / Revenue 1.72 x 1.58 x 1.52 x 1.26 x 1.14 x 1.17 x 1.16 x
EV / EBITDA 10.6 x 9.45 x 9.03 x 8.37 x 6.45 x 6.55 x 6.36 x
EV / FCF 23,254,464 x 10,042,087 x 16,191,345 x 10,075,191 x - - -
FCF Yield 0% 0% 0% 0% - - -
Price to Book 1.49 x 1.47 x 1.26 x 0.78 x 1.08 x 1.2 x 1.09 x
Nbr of stocks (in thousands) 160,879 160,913 160,913 160,933 160,933 159,056 -
Reference price 2 53.95 44.38 38.50 24.22 36.10 42.30 42.30
Announcement Date 2/13/20 2/10/21 2/10/22 2/10/23 2/8/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 11,935 12,288 12,867 14,496 17,287 19,148 19,388
EBITDA 1 1,940 2,053 2,166 2,174 3,045 3,419 3,537
EBIT 1 672 673 755 616 1,274 1,455 1,569
Operating Margin 5.63% 5.48% 5.87% 4.25% 7.37% 7.6% 8.09%
Earnings before Tax (EBT) 1 107 -926 103 -42 478 596.1 754.4
Net income 1 81 -904 56 -45 376 465 592
Net margin 0.68% -7.36% 0.44% -0.31% 2.18% 2.43% 3.05%
EPS 2 0.5100 -5.630 0.3500 -0.2800 2.330 2.940 3.720
Free Cash Flow 882 1,932 1,208 1,806 - - -
FCF margin 7.39% 15.72% 9.39% 12.46% - - -
FCF Conversion (EBITDA) 45.46% 94.11% 55.77% 83.07% - - -
FCF Conversion (Net income) 1,088.89% - 2,157.14% - - - -
Dividend per Share 2 - - - - 1.000 1.240 1.428
Announcement Date 2/13/20 2/10/21 2/10/22 2/10/23 2/8/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 3,338 3,482 3,546 3,679 3,789 4,044
EBITDA 511 507 481 673 513 -
EBIT 1 159 127 91 281 117 226
Operating Margin 4.76% 3.65% 2.57% 7.64% 3.09% 5.59%
Earnings before Tax (EBT) 1 - -42 -68 121 -53 36
Net income 1 -9 -33 -63 95 -44 28
Net margin -0.27% -0.95% -1.78% 2.58% -1.16% 0.69%
EPS - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/10/22 5/6/22 7/21/22 10/26/22 2/10/23 4/26/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 11,831 12,260 13,364 14,298 13,826 15,664 15,763
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) 6.098 x 5.972 x 6.17 x 6.577 x 4.541 x 4.581 x 4.457 x
Free Cash Flow 882 1,932 1,208 1,806 - - -
ROE (net income / shareholders' equity) 1.39% -17% 4.87% -0.91% 7.26% 8.52% 9.94%
ROA (Net income/ Total Assets) 0.39% -4.49% - -0.21% 1.66% 1.9% 2.18%
Assets 1 20,748 20,126 - 21,700 22,608 24,525 27,208
Book Value Per Share 2 36.20 30.10 30.70 31.10 33.30 35.30 38.90
Cash Flow per Share 7.630 14.10 8.560 - - - -
Capex 1 345 345 142 187 133 190 218
Capex / Sales 2.89% 2.81% 1.1% 1.29% 0.77% 0.99% 1.12%
Announcement Date 2/13/20 2/10/21 2/10/22 2/10/23 2/8/24 - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Attendo AB

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
42.3 SEK
Average target price
55 SEK
Spread / Average Target
+30.02%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ATTENDO AB Stock Attendo AB
+17.17% 605M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.87B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 83.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.72B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.4B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 15.04B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.88B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.88B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.86B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ATT Stock
  4. Financials Attendo AB